FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance

Frontiers in Immunology
Sara CaratelliGiuseppe Sconocchia

Abstract

For many years, disappointing results have been generated by many investigations, which have utilized a variety of immunologic strategies to enhance the ability of a patient's immune system to recognize and eliminate malignant cells. However, in recent years, immunotherapy has been used successfully for the treatment of hematologic and solid malignancies. The impressive clinical responses observed in many types of cancer have convinced even the most skeptical clinical oncologists that a patient's immune system can recognize and reject his tumor if appropriate strategies are implemented. The success immunotherapy is due to the development of at least three therapeutic strategies. They include tumor-associated antigen (TAA)-specific monoclonal antibodies (mAbs), T cell checkpoint blockade, and TAA-specific chimeric antigen receptors (CARs) T cell-based immunotherapy. However, the full realization of the therapeutic potential of these approaches requires the development of strategies to counteract and overcome some limitations. They include off-target toxicity and mechanisms of cancer immune evasion, which obstacle the successful clinical application of mAbs and CAR T cell-based immunotherapies. Thus, we and others have developed ...Continue Reading

References

Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G GrossZ Eshhar
Jun 1, 1994·Journal of Leukocyte Biology·P K WallaceM W Fanger
Oct 6, 1997·Journal of Virology·T J WickhamD M Segal
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Nov 5, 2003·Trends in Immunology·Per A AlbertssonPeter J K Kuppen
Dec 24, 2005·The New England Journal of Medicine·Franck PagèsJérôme Galon
Mar 28, 2008·Immunological Reviews·Paola AllavenaAlberto Mantovani
Jan 24, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frédéric BibeauFlorence Boissière-Michot
Mar 31, 2009·Current Opinion in Immunology·Michel SadelainIsabelle Rivière
Oct 27, 2009·International Journal of Cancer. Journal International Du Cancer·Daniel M FreyLuigi Tornillo
Dec 2, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tanja Schneider-MerckMichael Dechant
Mar 13, 2010·Current Gene Therapy·John S BridgemanDavid E Gilham
Apr 24, 2010·Nature Reviews. Immunology·Louis M WeinerShangzi Wang
Aug 18, 2010·International Journal of Cancer. Journal International Du Cancer·Giuseppe SconocchiaGiulio C Spagnoli
Feb 18, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·David M KoflerHinrich Abken
Apr 6, 2011·Expert Opinion on Biological Therapy·Carlos A Ramos, Gianpietro Dotti
May 5, 2011·The Journal of Clinical Investigation·Barbara SavoldoGianpietro Dotti
Oct 28, 2011·International Journal of Cancer. Journal International Du Cancer·Andreas A Hombach, Hinrich Abken
May 23, 2012·Trends in Molecular Medicine·David E GilhamHinrich Abken
Oct 11, 2012·Cancer Research·Giuseppe SconocchiaGiulio C Spagnoli
Feb 28, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raghvendra M SrivastavaRobert L Ferris
Feb 21, 2014·Science Translational Medicine·Marco L DavilaRenier Brentjens
Feb 25, 2014·Neoplasia : an International Journal for Oncology Research·Giuseppe SconocchiaLuigi Terracciano
Mar 29, 2014·The Cancer Journal·Hollie J PegramRenier J Brentjens
Dec 17, 2014·Clinical & Translational Immunology·Siok-Keen Tey
Jan 15, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Kevin J CurranRenier J Brentjens
May 23, 2015·Frontiers in Pharmacology·Raffaella GrecoFabio Ciceri
Jul 2, 2015·Nature Reviews. Drug Discovery·Sjoukje J C van der StegenMichel Sadelain
Jul 2, 2015·Frontiers in Medicine·Andrea CoppolaGiuseppe Sconocchia
Aug 19, 2015·Frontiers in Immunology·Wei WangPaul M Sondel
Apr 20, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroki TanakaMasaki Yasukawa

❮ Previous
Next ❯

Citations

Feb 11, 2018·Archivum Immunologiae Et Therapiae Experimentalis·Zohreh Sadat Badieyan, Sayed Shahabuddin Hoseini
Sep 4, 2019·International Journal of Cancer. Journal International Du Cancer·Sara CaratelliGiuseppe Sconocchia
Nov 11, 2018·British Journal of Cancer·Nicholas TokarewSebastian Kobold
May 20, 2020·Journal of Hematology & Oncology·Yonggui TianYi Zhang
Mar 28, 2019·Frontiers in Oncology·Nirav N ShahBryon Johnson
Dec 10, 2019·PLoS Biology·Eleanor M DenhamJesse Goyette
May 21, 2020·International Journal of Molecular Sciences·Nico M SieversNiels Schaft
Oct 23, 2020·Molecular Cancer Therapeutics·Sundee DeesIqbal S Grewal
Feb 12, 2020·Cancer Letters·Shengchao XuZhixiong Liu
Sep 12, 2017·Biochemical and Biophysical Research Communications·Takeshi KikuchiShun'ichiro Taniguchi
Apr 20, 2021·Frontiers in Oncology·Pooria Safarzadeh KozaniShahryar Khoshtinat Nikkhoi
May 3, 2021·Journal of Hematology & Oncology·Ying GongWilfred T V Germeraad
Jun 12, 2021·Frontiers in Neuroscience·Luke MaggsSoldano Ferrone
Aug 11, 2021·Pharmaceutics·Jasmine L King, Soumya Rahima Benhabbour
Aug 17, 2021·Computational and Mathematical Methods in Medicine·Ziang LiXuhong Zhou
Dec 19, 2021·Frontiers of Medicine·Jian-Qing MiSaijuan Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
genetic modifications

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

Related Papers

Translational Research : the Journal of Laboratory and Clinical Medicine
Masha ZeltsmanPrasad S Adusumilli
Translational Research : the Journal of Laboratory and Clinical Medicine
Dominique Bollino, Tonya J Webb
American Society of Clinical Oncology Educational Book
Oladapo YekuRenier J Brentjens
© 2022 Meta ULC. All rights reserved